Lupin concludes acquisition of 100% equity stake in Lab Grin

04 Oct 2014 Evaluate

Lupin has completed acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V., Mexico (Lab Grin) on September 30, 2014. Consequent to which, Lab Grin has become a wholly-owned subsidiary of the company with effect from September 30, 2014.

This acquisition marks the pharma major’s foray into the high growth Mexican and the larger Latin American pharmaceuticals market. Mexico is one of the fastest growing pharmaceutical markets in the world valued at over $13.5 billion and growing at 9-10% annually.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2322.45 68.55 (3.04%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×